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In the mature healthy mammalian neuronal networks, γ-aminobutyric acid (GABA)
mediates synaptic inhibition by acting on GABAA and GABAB receptors (GABAAR,
GABABR). In immature networks and during numerous pathological conditions the
strength of GABAergic synaptic inhibition is much less pronounced. In these neurons
the activation of GABAAR produces paradoxical depolarizing action that favors neuronal
network excitation. The depolarizing action of GABAAR is a consequence of deregulated
chloride ion homeostasis. In addition to depolarizing action of GABAAR, the GABABR
mediated inhibition is also less efficient. One of the key molecules regulating the
GABAergic synaptic transmission is the brain derived neurotrophic factor (BDNF). BDNF
and its precursor proBDNF, can be released in an activity-dependent manner. Mature
BDNF operates via its cognate receptors tropomyosin related kinase B (TrkB) whereas
proBDNF binds the p75 neurotrophin receptor (p75NTR). In this review article, we discuss
recent finding illuminating how mBDNF-TrkB and proBDNF-p75NTR signaling pathways
regulate GABA related neurotransmission under physiological conditions and during
epilepsy.
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INTRODUCTION
A striking trait of early GABAergic transmission is that activation of γ-aminobutyric acid
(GABAA) receptors (GABAARs) causes membrane depolarization and Ca2+ influx in immature
neurons (Ben-Ari et al., 1989, 2007; Ganguly et al., 2001). During this critical period, depolarizing
GABAAR activity plays a major role in neuronal network construction (Ben-Ari et al., 2007;
Wang and Kriegstein, 2008; Sernagor et al., 2010). Given this fundamental role it comes as
no surprise that flawed GABAergic transmission is implicated in an array of brain disorders
such as epilepsy (Ben-Ari and Holmes, 2005), autism spectrum disorder (ASD), Rett syndrome
(Kuzirian and Paradis, 2011), schizophrenia (Lewis et al., 2005; Charych et al., 2009; Mueller
et al., 2015) and major depressive disorder (Sanacora et al., 1999; Brambilla et al., 2003).
GABAergic development relies heavily on brain derived neurotrophic factor (BDNF; Hong
et al., 2008; Gottmann et al., 2009; Sakata et al., 2009; Kuzirian and Paradis, 2011), one of the
most crucial regulator of synapse development and function in the developing and adult central
nervous system (CNS; Lu et al., 2005; Cohen-Cory et al., 2010). BDNF can be secreted either as
a precursor (proBDNF) or a mature form (mBDNF; Nagappan et al., 2009; Yang et al., 2009).
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ProBDNF and mBDNF modulate the efficacy of synaptic
responses via the tropomyosin-related kinase receptor B (TrkB)
and the p75 neurotrophin receptor (p75NTR), respectively (Lu
et al., 2005). BDNF shapes the development of neuronal circuits,
as well as the construction of inhibitory connections throughout
life (Kovalchuk et al., 2004; Gubellini et al., 2005; Gottmann
et al., 2009) and alterations in BDNF processing have been
observed in diseases of the CNS, including schizophrenia, ASD
and epilepsy (Binder et al., 2001; Carlino et al., 2011; Garcia et al.,
2012). In this review article, we discuss the recent achievements
in analysis of the development of GABAergic network with
an emphasis on GABA and BDNF interplay. We particularly
focus on ionotropic GABAA or metabotropic GABAB receptors
activation in triggering the postsynaptic release of BDNF,
which in turn regulates the maturation of GABAergic synapses.
We then discuss how BDNF tunes up or down inhibitory
transmission by acting on synthesis and trafficking of GABAARs
and KCC2 chloride ion transporters at the cell membrane.
Finally, we focus on epilepsy, a pathology that highlights the links
between GABA and BDNF.
BDNF AND INHIBITORY STRENGTH OF
GABAA RECEPTORS
GABAARs are ionotropic receptors that allow the bidirectional
flux of chloride ions across the neuronal membrane. The
direction of Cl− flux depends on [Cl−]i and the membrane
potential, whereas the intensity of the flux depends on the
number of activated GABAARs. In mature healthy neurons
the [Cl-]i is close to 4 mM, and the reversal potential of
the ion flux through GABAARs (EGABAA) is ∼78–82 mV,
close to the resting membrane potential (Tyzio et al., 2003;
Khazipov et al., 2004). Hence, at rest, the activation of
GABAARs produces no or, at the most, a weak (1–2 mV)
hyperpolarization or depolarization. The activation of GABAARs
during neuronal depolarization induced by the excitatory
synapses allows massive Cl− entry that provides strong
hyperpolarizing force and effectively compensates or diminishes
the strength of the excitatory signal. The increased [Cl−]i is
rapidly extruded by electroneutral neuron-specific potassium-
chloride cotransporter KCC2 (Rivera et al., 1999). In immature
neurons as well as in mature neurons during different
pathologies (epilepsy (Cohen et al., 2002), acute trauma
(Boulenguez et al., 2010), Rett syndrome (Banerjee et al.,
2016), Down syndrome (Deidda et al., 2015), Huntington
disease (Dargaei et al., 2018), ASD (Tyzio et al., 2014))
the activation of GABAARs produces neuron depolarization
reflecting increased resting level of [Cl−]i. This Cl−-dependent
depolarization facilitated the activation of the neuronal network
and contributes to the formation of pathological patterns
of network activities (Ben-Ari et al., 2007; Moore et al.,
2017). Thus, the inhibitory strength of GABAAR mediated
inhibition is determined by two complementary parameters:
the amount of ion flux through opened GABAARs and the
[Cl−]i. The mBDNF and proBDNF do regulate these two
parameters.
ProBDNF, mBDNF AND GABAAR
INTERPLAY
Expression patterns of BDNF and proBDNF are developmentally
regulated. ProBDNF expression levels increase during the
first postnatal weeks while mature BDNF peaks at a later
period (Yang et al., 2014; Menshanov et al., 2015; Winnubst
et al., 2015). ProBDNF can be cleaved under physiological
conditions depending mainly on neuronal activity generated in
the developing neuronal networks (Lessmann and Brigadski,
2009; Nagappan et al., 2009; Langlois et al., 2013). For
instance, theta burst stimulation triggers the co-release of
proBDNF and the serine protease, tissue Plasminogen Activator
(t-PA) which converts plasminogen to plasmin yielding to
mature BDNF, whereas low-frequency stimulation increases the
amounts of proBDNF in the extracellular space (Nagappan
et al., 2009). Overexpression of proBDNF in proBDNF-HA/+
mice showed a decrease in dendritic arborization and spine
density of hippocampal neurons as well as altered synaptic
transmission (Yang et al., 2014). In developing rat hippocampal
neurons, proBDNF/p75NTR signaling has been reported to
induces a long-lasting depression of GABAAR-mediated synaptic
activity (Langlois et al., 2013), whereas endogenous BDNF/TrkB
signaling is required for the induction of GABAergic long-term-
potentiation (Gubellini et al., 2005).
In the cerebral cortex, BDNF/TrkB signaling controls
the development of interneurons (Yuan et al., 2016) and
the expression of the presynaptic GABA synthetic enzyme
GAD65 (Sánchez-Huertas and Rico, 2011). In the cerebellum,
BDNF promotes the formation of inhibitory synapses (Chen
et al., 2016). Postsynaptically, BDNF and proBDNF are
critical to control the GABAARs trafficking between synaptic
sites and endosomal compartments. The cell membrane
expression of GABAARs depends on their phosphorylation
level (Nakamura et al., 2015). Thus, dephosphorylation of the
GABAAR ß3 subunits triggers the association with the assembly
polypeptide 2 (AP2) complex which leads to a clathrin-mediated
internalization (Kittler et al., 2000; Nakamura et al., 2015).
In fact, BDNF/TrkB signaling inhibits the internalization of
GABAARs through activation of the phosphoinositide-3 kinase
(PI-3 kinase) and PKC pathways (Figure 1). This ability of
BDNF to modulate GABAARs endocytosis and activity is likely
to occur due to an inhibition of their interaction with the protein
phosphatase 2A complex (PP2A), a downstream target of PI-3
kinase (Jovanovic et al., 2004; Vasudevan et al., 2011). Inversely,
application of proBDNF to cultured rat hippocampal neurons
cause a reduction in GABAergic synaptic transmission by
promoting dephosphorylation and internalization of GABAAR
ß3 subunits through the RhoA–Rock–PTEN (phosphatase
and tensin homolog) signaling cascade (Riffault et al., 2014).
The underlying molecular mechanism of PTEN-mediated
dephosphorylation and downregulation of GABAARs remains
to be determined but may involve the inhibition of PI3-kinase
activity and the subsequent upregulation of PP2A activity.
Accordingly, PTEN activated by p75NTR is a major negative
regulator of the PI3-kinase signaling cascade (Song et al.,
2010). Thus, the cell surface expression levels of GABAARs
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FIGURE 1 | mBDNF/TrkB and proBDNF/p75NTR signaling pathways regulate γ-aminobutyric acid (GABA) neurotransmission. Activation of TrkB receptors by mBDNF
leads to an inhibition of GABAAR endocytosis and a consequent increase in the cell surface expression of these receptors through the PI 3-kinase and the PKC
signaling pathway. At the transcriptional level, BDNF/TrkB signaling regulates GABAAR and KCC2 gene expression through the Shc, PLC/CaMK or MAP/ERK
pathways. Activation of p75NTR by proBDNF decreases GABAARs cell surface expression through the RhoA/ROCK/PTEN pathway that leads to the
dephosphorylation of GABAAR and endocytosis and degradation of internalized receptors. At the transcriptional level, proBNDF/P75NTR leads to the repression of
GABAAR synthesis through the JAK2/STAT3/ICER pathway. The proBDNF/75NTR signaling also decreases KCC2 expression.
can be settled by the competition between mBDNF/TrkB and
proBDNF/p75NTR intracellular cascades on the PTEN/PI3-
kinase-mediated activation of PP2A. After endocytosis, the
proBDNF/p75NTR/Rho-ROCK pathway moved internalized
GABAARs to late endosomes and finally to lysosomes for
degradation (Riffault et al., 2014).
The BDNF may also be involved in GABAARs clustering at
synaptic sites through the regulation of the main scaffolding
protein gephyrin. Indeed, in immature rat hippocampal neuronal
cultures BDNF enhanced the expression and clustering of
gephyrin, which in turn leads to an increase in the density
of GABAARs-gephyrin containing complexes at postsynaptic
sites (González, 2014). Conversely, in cultured mouse amygdala
neurons, rapid application of BDNF decreased the cell surface
expression of GABAARs-gephyrin complexes whereas long-term
treatment with BDNF elicits opposite effects (Mou et al., 2013).
BDNF can exert different roles depending on the developmental
stages (young vs. adult neurons) but also in function of the
brain structures or according to the delivery mode (rapid vs.
long-term treatment). These opposing responses of BDNF on
GABAARS clustering may reflect the differences in the kinetics
of TrkB activation (Ji et al., 2010) and may contribute to
the homeostatic regulation of GABAergic synaptic strength
(Tyagarajan and Fritschy, 2010; Vlachos et al., 2013; Brady et al.,
2018).
After its release into the synaptic cleft, the activity of
GABA is terminated by the reuptake of the neurotransmitter, a
process mediated by the GABA transporters (GATs). The surface
expression of GABA transporter-1 (GAT-1), the major GABA
transporter expressed by both neurons and astrocytes (Guastella
et al., 1990), is upregulated in neuronal cells by BDNF-mediated
tyrosine kinase-dependent phosphorylation (Law et al., 2000;
Whitworth and Quick, 2001). However, the neurotrophin was
found to inhibit GAT-1-mediated GABA transport at the isolated
nerve endings (Vaz et al., 2008), suggesting that this effect is very
localized, to delay GABA uptake by the nerve terminal, thereby
enhancing synaptic actions of GABA. In contrast with the effects
at the synapse, BDNF may accelerate the uptake of GABA at
extrasynaptic sites, allowing replenishment of neuronal pools of
GABA. Furthermore, BDNF enhances GABA transport in rat
cortical astrocytes by modulating the trafficking of GAT-1 from
the plasma membrane (Vaz et al., 2011).
BDNF also regulates genes transcription of GABAAR subunits
(Bell-Horner et al., 2006) GAD65 (Sánchez-Huertas and Rico,
2011) and GATs (Vaz et al., 2011), through the recruitment of the
ERK-MAP kinase cascade, which activates the cAMP-response
element (CRE)-binding protein (CREB; Figure 1; Yoshii and
Constantine-Paton, 2010). In an opposite way, the downstream
signaling pathway triggered by proBDNF/p75NTR activates the
JAK-STAT pathway leading to the induction of the cAMP
early repressor ICER, which mediates the downregulation of
GABAARs ß3 gene synthesis (Figure 1). Interestingly, the
activation of this pathway precedes the decrease of GABAARs
ß3 cell surface expression (Riffault et al., 2014).
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Other reports have also suggested that in rat visual
cortex and cerebellar Purkinje cells, the BDNF/TrkB signaling
modulates GABAARs mediated currents through the PLCγ-
Ca2+ and CaMK pathways (Cheng and Yeh, 2003; Mizoguchi
et al., 2003). In immature cultured rat hippocampal and
hypothalamic neurons, the BDNF/TrkB dependent increase in
GABAARs plasma membrane expression occurs when activation
of GABAARs lead to a depolarization of the membrane potential,
which in turn triggers the release of BDNF (Obrietan et al., 2002;
Porcher et al., 2011). In more mature cultured rat hippocampal
neurons and murine cerebellar granule cells, BDNF decreases
the plasma membrane expression of GABAARs (Brünig et al.,
2001; Cheng and Yeh, 2003). In parallel, BDNF/trkB signaling
reduces the excitability of parvalbumin-positive interneurons
in the mouse dentate gyrus (Holm et al., 2009). Surprisingly,
these neurons do not express the proBDNF receptor p75NTR
(Dougherty and Milner, 1999; Holm et al., 2009). The change
in the regulation of GABAARs cell surface expression by BDNF
coincides with a shift in GABA polarity (depolarization to
hyperpolarization), attributed to the activity of KCC2 (Rivera
et al., 1999) which is also regulated by both forms of BDNF. A
recent study showed that increased proBDNF/p75NTR signaling
disrupts the developmental GABAergic sequence by maintaining
a depolarizing GABA response in a KCC2-dependent manner
in mature cortical neurons (Riffault et al., 2018). In developing
neurons, BDNF increases KCC2 expression on the level of
mRNA transcription (Aguado et al., 2003; Rivera et al., 2004;
Ludwig et al., 2011). In line with these observations, it was
shown that the expression of KCC2 is significantly decreased
in trkB−/− mice hippocampi (Carmona et al., 2006) whereas,
in adult neurons BDNF decreases both mRNA and protein
KCC2 (Rivera et al., 2002, 2004; Wake et al., 2007; Shulga et al.,
2008; Boulenguez et al., 2010). In accordance with these results,
neurons in the dorsal horn of the spinal cord treated with BDNF
showed a depolarizing shift of the GABA reversal potential
(Coull et al., 2003, 2005). The actions of BDNF/TrkB signaling
on GABAergic synapses are developmentally regulated, with
BDNF leading to an increase of KCC2 expression in immature
neurons through activation of Shc pathway, and a decrease in
adult neurons through activation of both Shc and PLCγ cascades
(Rivera et al., 2002, 2004; Figure 1).
Altogether, these findings suggest that the relative availability
of the two forms of BDNF, pro and mature, could affect
the excitatory/inhibitory balance during the development by
regulating the polarity and the synaptic strength of GABAergic
transmission.
GABABR AND BDNF INTERPLAY
Similarly to BDNF, a crucial factor regulating the development
of inhibitory transmission is GABA itself (Ben-Ari et al.,
2007; Gaiarsa et al., 2011). In the neocortex, extracellular
GABA signaling regulates the development of GABAergic
inhibition through GABAA and GABAB receptors. During the
developmental period, ambient GABA may also participate in
neuronal network construction and synaptogenesis. In the visual
cortex of mice, Chattopadhyaya et al. (2007) demonstrated
that the tonic activation of GABAA and GABAB receptors
regulates the axonal branching of basket-cell interneurons. They
reported that reducing GABA levels in a single basket cell
results in a decrease of perisomatic GABAergic inputs on the
pyramidal cells. This deficit of synaptic transmission is partially
restored by GABA uptake blocker or GABAA and GABAB
receptor agonists. In agreement with this study, knockout of
the GABAB1 subunit leads to altered maturation of GABAergic
synaptic transmission in murine hippocampal neurons and
synaptic activation of GABABRs promotes the development of
GABAergic synapses (Fiorentino et al., 2009). The mechanisms
are not fully understood but may likely involve the BDNF/TrkB
signaling. Indeed, the trophic action of GABABRs was prevented
by BDNF scavenger (TRkB-IgG) and not observed in BDNF
KO mice (Fiorentino et al., 2009). Moreover, the stimulation
of GABABRs induce a calcium-dependent release of BDNF
via the PLC-PKC signaling cascade and L-type voltage-gated
calcium channels (Fiorentino et al., 2009; Kuczewski et al., 2011).
Finally, in the developing rat hippocampus, it was shown that
activation of GABABRs also increased the phosphorylation levels
of the α-CamKII, which play a critical role in BDNF release
(Fischer et al., 2005; Kolarow et al., 2007; Xu et al., 2008).
Therefore, postsynaptic calcium increase and phosphorylation
of α-CamKII may underlie the GABAB-R-mediated release
of BDNF. Interestingly, the regulated secretion of BDNF
following GABAB receptor activation increases the number of
GABAA ß2/3 subunits receptors at the postsynaptic membrane
(Kuczewski et al., 2011). Thus, the interplay between GABABRs
activation and the subsequent BDNF secretion in developing
hippocampal neurons contribute to the functional maturation of
GABAergic synaptic transmission.
BDNF AND GABA INTERPLAY IN EPILEPSY
Epilepsy is a brain disorder characterized by the appearance of
spontaneous recurrent seizures due to network hyperexcitability
(Fischer et al., 2005). Neurotrophic signaling pathways are
over-activated after status epilepticus (SE) and seem to
contribute to epileptogenesis by promoting neuronal cell
deaths and rewiring of excitatory networks (Koyama et al.,
2004; Unsain et al., 2008; Goldberg and Coulter, 2013).
Similarly, changes in GABAergic neurotransmission and altered
neuronal Cl− homeostasis are considered to play a crucial role
in epileptogenesis. Initial studies regarding the contribution
of BDNF to epilepsy led to conflicting conclusions, with
intrahippocampal BDNF perfusion or intraventricular injection
of the BDNF scavenger TrkB-IgG, both being protective in
a model of dorsal hippocampal kindling (Reibel et al., 2000;
Binder et al., 2001). However, further studies reported that
epileptogenesis was suppressed in mice with conditional deletion
of TrkB in the brain (He et al., 2004) as well as in mice
carrying a TrkB gene mutation that uncouples TrkB from the
PLCγ (He et al., 2010). Interestingly, elevated levels of BDNF
and TrkB following seizure activity or bath application of
BDNF on hippocampal neurons trigger a down-regulation of
KCC2 surface expression and a subsequent increase in neuronal
excitability which most likely contributes to the establishment
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FIGURE 2 | Scheme summarizing the causal relationship between
proBDNF/p75NTR and depolarizing action of GABA during epileptogenesis.
Elevated amounts of proBDNF following status epilepticus (SE) are associated
with reduced proBDNF cleavage machinery and increased expression of
p75NTR. The proBDNF/p75NTR response donwregulates KCC2, which
promotes a chloride homeostasis dysregulation leading to an excitatory action
of GABA and facilitate recurrent seizures.
of recurrent seizures (Rivera et al., 2002; Wake et al., 2007). In
addition to the pro-epileptogenic effect of mBDNF, it has been
shown that proBDNF and p75NTR are markedly increased after
Pilocarpine-induced seizures. The elevated amounts of proBDNF
following SE are associated with reduced proBDNF cleavage
machinery that results from acute decreases in tPA/plasminogen
proteolytic cascade and increases in API-1, an inhibitor of
proBDNF cleavage (Reibel et al., 2000; Binder et al., 2001).
Furthermore, two recent studies showed that proBDNF/p75NTR
response following SE selectively downregulates KCC2, which in
turn promotes a chloride homeostasis dysregulation leading to an
excitatory action of GABAA receptors and facilitate epileptiform
discharges (Kourdougli et al., 2017; Riffault et al., 2018; Figure 2).
Interestingly, blockade of p75NTR during the earliest phase
of epileptogenesis restores KCC2 levels and reduces seizures
frequency (Kourdougli et al., 2017; Riffault et al., 2018). These
results suggest that proBDNF/p75NTR play a critical role in
the mechanisms of epileptogenesis (see Figure 2). It should
be pointed, however, that apart from these pro-epileptogenic
actions, BDNF could exert anti-epileptic effects (Paradiso et al.,
2009; Bovolenta et al., 2010). Several observations support the
view that at least part of the pro-epileptogenic actions of
pro- or mature-BDNF relies on an alteration of GABAergic
inhibition. Thus, although BDNF exerts beneficial effects on
developing GABAergic synapses, exogenous applications of this
neurotrophin decrease the efficacy of GABAergic inhibition
on mature neurons (Berninger et al., 1995; Mizoguchi et al.,
2003). In cultured hippocampal neurons, proBDNF promotes
GABAA receptor endocytosis and degradation (Riffault et al.,
2014) and BDNF has been reported to reduce the probability
of GABA release (Mizoguchi et al., 2003). At the transcriptional
level, BDNF/TrkB signaling causes the repression of GABAARs
α1 subunit gene through the activation of JAK-STAT pathway
following SE (Lund et al., 2008). An important feature of
epileptogenesis is a downregulation of KCC2 expression both
in human epileptogenic tissues (Aronica et al., 2007; Huberfeld
et al., 2007; Munakata et al., 2007; Shimizu-Okabe et al., 2011;
Kahle et al., 2014) and in animal models of epilepsy (Jin et al.,
2005; Kourdougli et al., 2017; Riffault et al., 2018). In patients
with temporal lobe epilepsy, the decrease in KCC2 expression
results in depolarizing GABAergic events in a minority of
subicular pyramidal cells that contribute to inter-ictal like
activity (Cohen et al., 2002; Huberfeld et al., 2007). These
findings are consistent with reports of KCC2 downregulation
and changes in the polarity of GABAergic response in animal
models of epilepsy (Huberfeld et al., 2007; Barmashenko et al.,
2011; Shimizu-Okabe et al., 2011; Kourdougli et al., 2017;
Riffault et al., 2018). Because both forms of BDNF regulate
the expression of KCC2 (Rivera et al., 1999; Ludwig et al.,
2011), the decrease observed in epileptic tissues could be due
to an imbalance between mBDNF/TrkB and proBDNF/p75NTR
signaling during the first postnatal weeks causing an impaired
or delayed functional maturation of GABAergic inhibition.
Alternatively, an excess of BDNF production and secretion
associated with reductions in proBDNF cleavage in epileptic
tissues (Ernfors et al., 1991; Thomas et al., 2016) could
account for the decrease in KCC2 expression (Figure 2).
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Altogether, these findings show a complex picture in which
BDNF signaling can influence the pathogenicity of epilepsy
both ways. Further studies will be necessary to precise the
role of the extracellular proBDNF/mBDNF ratio in GABAergic
transmission during neuronal development and in different types
of epilepsies.
Unveiling the mode of action of BDNF in the development
and functioning of the GABAergic network is a promising
quest for developing new cures of a number of neurological
diseases. BDNF influences the development and functioning of
the GABAergic network which in turn controls BDNF levels.
As a result of this interaction, impairment of one of the two
systems will most disturb the other, and since each of them is
fundamental to normal CNS functioning, this will potentially
lead to a host of neurological conditions. As of today, there
is hope that investigation of the molecular pathways mediating
the trophic action of BDNF may provide new insights into
the normal development of the GABAergic network, providing
new therapeutic strategies to improve the symptoms in a broad
spectrum of GABA-related pathologies.
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